BioTD: An Online Database of Biotoxins
Clinical Snapshot
PICO Framework
| P — Population | Researchers and drug discovery scientists working with biotoxins derived from venomous animals, plants, and microorganisms |
| I — Intervention | BioTD — a newly developed open-source online database aggregating biotoxin structural, activity, safety, kinetic, and sequence data from published literature and patents |
| C — Comparator | Existing biotoxin and toxin-related databases (implicitly compared in terms of scope, data volume, and accessibility) |
| O — Outcomes | Database coverage (number of toxins, activity records, species, references), data categorisation quality, accessibility, and utility for drug discovery and computational research |
Bottom Line
BioTD represents a timely and potentially valuable open-access resource for the biotoxin drug discovery community, aggregating 8,975 toxins and 8,185 activity records from over 5,220 references and patents across 900+ species into a single freely downloadable platform. The database addresses a genuine gap in consolidated, structured biotoxin data, particularly given the growing pipeline of venom-derived therapeutics — from ziconotide (conotoxin-derived analgesic) to captopril (bradykinin-potentiating peptide-inspired antihypertensive). For Australian researchers, the resource is especially pertinent given Australia's unparalleled venomous biodiversity. However, the abstract provides insufficient methodological detail to fully assess curation rigour, data standardisation, or completeness relative to the primary literature. The absence of benchmarking against existing databases, inter-curator reliability data, and any demonstration of downstream utility limits confidence in the resource's accuracy claims. Senior clinicians and researchers should treat BioTD as a useful hypothesis-generating and data-aggregation tool, while applying critical scrutiny to individual activity records — particularly given the known heterogeneity of assay conditions across the source literature. Independent validation and community uptake over the coming years will be the true test of this resource's impact.
Key Findings
P Value: Not applicable — no hypothesis testing performed
Effect Size: Not applicable — this is a database development study; no effect size is reported or calculable
Primary Outcome: Development and public release of BioTD, described as the largest open-source biotoxin database, containing 14,607 data records including 8,185 activity records, covering 8,975 toxins from 5,220 references and patents across over 900 species
Nnt Or Sensitivity: Not applicable — no clinical outcome, diagnostic accuracy, or survival data reported; database coverage metrics serve as the primary descriptive outputs
Confidence Interval: Not reported — no statistical analyses with confidence intervals are presented in the abstract
Clinical Application
High feasibility for research use — the database is freely accessible online at http://biotoxin.net/ with full data download capability. No specialist software or institutional subscription is required. Integration into drug discovery pipelines will require additional computational expertise. Clinical translation from database-derived leads remains a lengthy, resource-intensive process. Australia has exceptional relevance to biotoxin research given its unique venomous fauna, including the world's most toxic elapid snakes (e.g., inland taipan, eastern brown snake), funnel-web spiders, cone snails, stonefish, and box jellyfish. BioTD may support Australian researchers at institutions such as the Australian Venom Research Unit (University of Melbourne) and the Venom Evolution Lab (University of Queensland). Clinically, Australian emergency physicians and toxicologists managing envenomation may benefit indirectly from improved biotoxin characterisation. The TGA has approved ziconotide (derived from cone snail conotoxin) for intractable pain — a precedent for Australian venom-derived drug development. The RACGP and ACEM have no direct guidelines referencing biotoxin databases, but the resource may inform future antivenom development and PBS listing applications for novel venom-derived therapeutics. No PBS or TGA regulatory implications arise directly from the database itself. Primarily applicable to preclinical researchers, computational chemists, toxinologists, and pharmaceutical scientists engaged in venom-derived drug discovery. Indirect clinical relevance for clinicians managing envenomation, developing antivenoms, or investigating novel analgesic, antihypertensive, or anticoagulant agents derived from biotoxins.
Abstract
Biotoxins, mainly produced by venomous animals, plants, and microorganisms, exhibit high physiological activity and unique effects such as lowering blood pressure and analgesia. A number of venom-derived drugs are already available on the market, with many more candidates currently undergoing clinical and laboratory studies. However, drug design resources related to biotoxins are insufficient, particularly because of a lack of accurate and extensive activity data. To fulfill this demand, we developed the Biotoxins Database (BioTD). BioTD is the largest open-source database for toxins, offering open access to 14,607 data records (8,185 activity records), covering 8,975 toxins sourced from 5,220 references and patents across over 900 species. The activity data in BioTD are categorized into five groups: Activity, Safety, Kinetics, Hemolysis, and other physiological indicators. Moreover, BioTD provides data on 1,532 mutants, refines the whole sequence and signal peptide sequences of toxins, and annotates disulfide-bond information. All of the data in the database can be downloaded for free. Given the importance of biotoxins and their associated data, this new database is expected to attract broad interest from diverse research fields in drug discovery. BioTD is freely accessible at http://biotoxin.net/.
References
- 1.Wang, G., Wu, H., Liao, Y., Chen, Z., Zhou, Q., Wang, W., Liu, Y., Wang, Y., Wu, M., Xiang, R., Yu, Y., Zhou, X., Zhu, F., Liu, Z., & Hou, T. (2026). BioTD: An online database of biotoxins. Journal of Chemical Information and Modeling. Advance online publication. https://doi.org/10.1021/acs.jcim.6c00682
Related Research
Archives of toxicology
A review of machine learning in toxicology: current practices and reporting gaps
2 Aug 2026
Cardiovascular toxicology
Mechanisms of Cardiovascular Toxicity Induced by Silver Nanoparticles: A Systematic Review of Preclinical Evidence
13 July 2026
JMIR infodemiology
Self-Reported Tianeptine Experiences on Reddit: Natural Language Processing-Assisted Qualitative Study
8 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service